INTERNATIONAL PATENT: FRACTYL HEALTH, INC. FILES APPLICATION FOR "GLP-1 GENE THERAPIES FOR METABOLIC DISORDERS"

GENEVA, July 14 -- FRACTYL HEALTH, INC. (3 Van de Graaff DriveSuite 200Burlington, MA 01803) filed a patent application (PCT/US2025/010262) for "GLP-1 GENE THERAPIES FOR METABOLIC DISORDERS" on Jan 03, 2025. With publication no. WO/2025/147630, the details related to the patent application was published on Jul 10, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): QUEK, Lin (3 Van de Graaff DriveSuite 200Burlington, MA 01803), WANG, Suya (3 Van de Graaff DriveSuite 200Burlington, MA 01803), WHITE, Gary (3 Van de Graaff DriveSuite 200Burlington, MA 01803)

Abstract: An adeno-associated viral g...